Here’s thing
Analysts are calling $187 per Sarepta share
That’s almost a MC of 18 billion $$
At the moment Sarepta have a MC of $16 billion
earnings are $353 million but they are yet to make a profit..
Some say Sarepta could earn $1 billion next year ?
Now
All the drugs have not shown efficacy or produced the end points in their trails
The FDA has definitely set a PRECEDENT
ok
So one can ask?
What’s it got to do with PER ?
In my opinion as long as the Tox study is a given
I firmly believe Atl1102 will be a winner
In DMD and LGMD
Do the sums .. a MC of $5 billion is reachable $$
https://www.bloomberg.com/news/newsl
https://www.bloomberg.com/news/newsl
- Forums
- ASX - By Stock
- PER
- FDA approves Sareptas Srp901 for the whole population
FDA approves Sareptas Srp901 for the whole population, page-40
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.0¢ |
Change
-0.002(2.44%) |
Mkt cap ! $72.12M |
Open | High | Low | Value | Volume |
8.3¢ | 8.4¢ | 8.0¢ | $58.49K | 703.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 127624 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.4¢ | 25545 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 127624 | 0.080 |
1 | 3600 | 0.079 |
1 | 10000 | 0.077 |
3 | 86800 | 0.075 |
3 | 180866 | 0.074 |
Price($) | Vol. | No. |
---|---|---|
0.084 | 25545 | 1 |
0.085 | 363000 | 2 |
0.086 | 480000 | 3 |
0.087 | 400000 | 1 |
0.088 | 406000 | 2 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |